JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.74 CNY | +4.78% |
|
+4.37% | +1.90% |
| Sales 2024 * | 954M 132M 10.99B | Sales 2025 * | 1.2B 166M 13.81B | Capitalization | 4.51B 622M 51.92B |
|---|---|---|---|---|---|
| Net income 2024 * | 141M 19.48M 1.62B | Net income 2025 * | 191M 26.38M 2.2B | EV / Sales 2024 * | 4.72 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.76 x |
| P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
23.6
x | Employees | 1,280 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.58% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.78% | ||
| 1 week | +4.37% | ||
| Current month | +44.35% | ||
| 1 month | +44.35% | ||
| 3 months | +33.09% | ||
| 6 months | -4.45% | ||
| Current year | +1.90% |
1 week
9.58
10.99
1 month
7.2510.99
Current year
5.7610.99
1 year
5.7613.75
3 years
5.7626.17
5 years
4.5126.17
10 years
4.0726.17
| Managers | Title | Age | Since |
|---|---|---|---|
Zheng Wei Pang
CEO | Chief Executive Officer | 62 | 01/05/01 |
Jin Qiao Hu
DFI | Director of Finance/CFO | 41 | 20/04/20 |
Hui Gang Jiang
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/09/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Wan
BRD | Director/Board Member | 63 | 13/22/13 |
Xin Peng
BRD | Director/Board Member | 52 | 28/21/28 |
Zheng Wei Pang
CEO | Chief Executive Officer | 62 | 01/05/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 10.74 | +4.78% | 10,059,150 |
| 29/24/29 | 10.25 | -0.58% | 7,032,745 |
| 26/24/26 | 10.31 | -0.77% | 10,242,500 |
| 25/24/25 | 10.39 | +4.95% | 14,044,460 |
| 24/24/24 | 9.9 | -1.20% | 9,818,144 |
End-of-day quote Shenzhen S.E., April 30, 2024
More quotes
Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.
Sector
Pharmaceuticals
Calendar
17/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.74
CNY
Average target price
9.3
CNY
Spread / Average Target
-13.41%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +1.90% | 622M | |
| +31.56% | 699B | |
| +25.10% | 571B | |
| -4.15% | 364B | |
| +18.47% | 326B | |
| +2.83% | 286B | |
| +14.53% | 236B | |
| +4.57% | 198B | |
| -12.19% | 194B | |
| -3.87% | 154B |
- Stock Market
- Equities
- 300636 Stock
